Literature DB >> 27085091

High prevalence of individuals with low concentration of fetal hemoglobin in F-cells in sickle cell anemia in Tanzania.

Florence Urio1,2, Magdalena Lyimo3, Siana Nkya Mtatiro1, Sharon E Cox1,4,5, Bruno P Mmbando1,6, Julie Makani1,3,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27085091      PMCID： PMC5612395          DOI： 10.1002/ajh.24390

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea.

Authors:  M H Steinberg; Z H Lu; F B Barton; M L Terrin; S Charache; G J Dover
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

Review 2.  X-linked dominant control of F-cells in normal adult life: characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome.

Authors:  K Miyoshi; Y Kaneto; H Kawai; H Ohchi; S Niki; K Hasegawa; A Shirakami; T Yamano
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

3.  Fetal hemoglobin in sickle cell anemia: a glass half full?

Authors:  Martin H Steinberg; David H K Chui; George J Dover; Paola Sebastiani; Abdulrahman Alsultan
Journal:  Blood       Date:  2013-11-12       Impact factor: 22.113

4.  Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in congolese patients with sickle cell anaemia.

Authors:  L Tshilolo; V Summa; C Gregorj; C Kinsiama; J A Bazeboso; G Avvisati; D Labie
Journal:  Anemia       Date:  2012-07-05

5.  Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.

Authors:  Siana Nkya Mtatiro; Julie Makani; Bruno Mmbando; Swee Lay Thein; Stephan Menzel; Sharon E Cox
Journal:  Am J Hematol       Date:  2014-10-20       Impact factor: 10.047

6.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.

Authors:  Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Lancet       Date:  2012-10-25       Impact factor: 79.321
  6 in total
  3 in total

1.  Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.

Authors:  Yan Dai; Jose Sangerman; Mehdi Nouraie; Aidan D Faller; Patricia Oneal; Angela Rock; Oluwakemi Owoyemi; Xiaomei Niu; Sergei Nekhai; Dashmeet Maharaj; Shauiying Cui; Robert Taylor; Martin Steinberg; Susan Perrine
Journal:  Am J Hematol       Date:  2016-11-18       Impact factor: 10.047

2.  Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.

Authors:  Betty S Pace; Susan Perrine; Biaoru Li; Levi Makala; Hongyan Xu; Mayuko Takezaki; Roman F Wolf; Amy Wang; Xin Xu; Junfeng Huang; Asaf Alimardanov; Gregory J Tawa; Jose Sangerman; Aidan Faller; Wei Zheng; London Toney; Sharie J Haugabook
Journal:  Blood Cells Mol Dis       Date:  2021-03-12       Impact factor: 2.372

3.  Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.

Authors:  Charles T Quinn; Omar Niss; Min Dong; Amanda Pfeiffer; Jennifer Korpik; Mary Reynaud; Holly Bonar; Theodosia A Kalfa; Luke R Smart; Punam Malik; Russell E Ware; Alexander A Vinks; Patrick T McGann
Journal:  Br J Haematol       Date:  2021-07-05       Impact factor: 8.615
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.